Plasma osteopontin in acute liver failure

Cytokine

Volumn 73, Issue 2, 2015, Pages 270-276

  Srungaram, Praveen ^a   Rule, Jody A ^a   Yuan, He Jun ^a   Reimold, Andreas ^a   Dahl, Benny ^b   Sanders, Corron ^a   Lee, William M ^a,c   Larson, Anne M ^c   Liou, Iris ^c   Davern, Timothy ^d   Fix, Oren ^e   Schilsky, Michael ^f,g   McCashland, Timothy ^h   Hay, J Eileen ⁱ   Murray, Natalie ^j   Shaikh, A Obaid S ^k   Blei, Andres ^a   Ganger, Daniel ^l   Zaman, Atif ^m   Han, Steven H B ⁿ   Fontana, Robert ^o   McGuire, Brendan ^p   Chung, Raymond T ^q   Smith, Alastair ^r   Brown, Robert ^s   Crippin, Jeffrey ^t   Harrison, Edwin ^u   Reuben, Adrian ^v   Munoz, Santiago ^w   Reddy, Rajender ^x   Stravitz, R Todd ^y   Rossaro, Lorenzo ^z   Satyanarayana, Raj ^aa   Hassanein, Tarek ^ab   more..

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of Copenhagen   (Denmark)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g YALE UNIVERSITY   (United States)

^h UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

ⁱ MAYO CLINIC   (United States)

^j BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^k UNIVERSITY OF PITTSBURGH   (United States)

^l NORTHWESTERN UNIVERSITY   (United States)

^m UNIVERSITY OF OREGON   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o UNIVERSITY OF MICHIGAN   (United States)

^p UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^q MASSACHUSETTS GENERAL HOSPITAL   (United States)

^r DUKE UNIVERSITY MEDICAL CENTER   (United States)

^s Washington University ^*  (United States)

^t WASHINGTON UNIVERSITY   (United States)

^u MAYO CLINIC   (United States)

^v MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^w ALBERT EINSTEIN MEDICAL CENTER   (United States)

^x UNIVERSITY OF PENNSYLVANIA   (United States)

^y VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^z UNIVERSITY OF CALIFORNIA   (United States)

^aa MAYO CLINIC   (United States)

^ab UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Acute liver failure; Cytokine; Inflammation; Liver necrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN; OSTEOPONTIN; PARACETAMOL;

ACUTE LIVER FAILURE; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HUMAN; INTERNATIONAL NORMALIZED RATIO; ISCHEMIA; LEUKOCYTE COUNT; LIVER CELL DAMAGE; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; ONSET AGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SHOCK; SPINE FUSION; THROMBOCYTE COUNT; TOXIC HEPATITIS; VIRUS HEPATITIS; BLOOD; CASE CONTROL STUDY; DEMOGRAPHY; LIVER FAILURE, ACUTE; MIDDLE AGED; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; OSTEOPONTIN; PROGNOSIS; RISK FACTORS; SPINAL FUSION; YOUNG ADULT;

EID: 84925424640     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.02.021     Document Type: Article

References (31)

1. Ostapowicz G., Fontana R.J., Schiødt F.V., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Int Med 2002, 137(12):947-954.
2. Antoniades C.G., Berry P.A., Wendon J.A., Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 2008, 49(5):845-861.
3. Oldberg A., Franzen A., Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 1986, 83(23):8819-8823.
4. Uede T. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int 2011, 61(5):265-280.
5. Diao H., Kon S., Iwabuchi K., et al. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 2004, 21(4):539-550.
6. Diao H., Iwabuchi K., Lanjuan L., et al. Osteopontin regulates development and function of invariant natural killer T cells. Proc Natl Acad Sci USA 2008, 105(41):15884-15889.
7. Lund S.A., Giachelli C.M., Scaena M. The role of osteopontin in inflammatory processes. J Cell Commun Signal 2009, 3:311-322.
8. Zhang C.H., Xu G.L., Jia W.D., et al. Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis. Int J Cancer 2012, 130(11):2685-2692.
9. Shang S., Plymoth A., Ge S., et al. Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology 2012, 55(2):483-490.
10. Inoue M., Shinohara M.L. Intracellular osteopontin (iOPN) and immunity. Immunol Res 2011, 49(1-3):160-172.
11. Matsui A., Mochida S., Ohno A., Nagoshi S., Hirose T., Fujiwara K. Plasma osteopontin levels in patients with fulminant hepatitis. Hepatol Res 2004, 29(4):202-206.
12. Arai M., Yokosuka O., Kanda T., et al. Serum osteopontin levels in patients with acute liver dysfunction. Scand J Gastroenterol 2006, 41(1):102-110.
13. Polson J., Lee W.M. AASLD position paper: the management of acute liver failure. Hepatology 2005, 41(5):1179-1197.
14. Mikuls T.R., Kazi S., Cipher D., et al. The association of race and ethnicity with disease expression in male US veterans with rheumatoid arthritis. J Heumatol 2007, 34(7):1480-1484.
15. Bautista D.S., Saad Z., Chambers A.F., et al. Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women. Clin Biochem 1996, 29(3):231-239.
16. Fedarko N.S., Jain A., Karadag A., Van Eman M.R., Fisher L.W. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 2001, 7(12):4060-4066.
17. Filia A., Elliot F., Wind T., et al. Plasma osteopontin concentrations in patients with cutaneous melanoma. Oncol Rep 2013 Oct, 30(4):1575-1580. [Epub August 8, 2013]. 10.3892/or.2013.2666.
18. Hotte S.J., Winquist E.W., Wilson S.M., et al. Plasma osteopontin: association with survival and metastasis to bone in men with hormone-refractory prostate carcinoma. Cancer 2002, 95(3):506-512.
19. Han S., Mali A.M. Estimation and comparison of osteopontin levels in plasma in subjects with healthy periodontium and generalized chronic periodontitis and its assessment after scaling and root planing. J Indian Soc Periodontol 2012, 16(3):354-357.
20. Kawashima R., Mochida S., Matsui A., et al. Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun 1999, 256(3):527-531.
21. Ramaiah S.K., Rittling S. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci 2008, 103(1):4-13.
22. Kamath P.S., Kim W.R. The model for end-stage liver disease (MELD). Hepatology 2007, 45:797-805.
23. Koh H.S., Matsui A., Mimura S., et al. Increased cytoprotective function in the liver of transgenic mice expressing osteopontin in hepatocytes. Hepatol Res 2005, 32(1):46-51.
24. Arai M., Yokosuka O., Fukai K., et al. Gene expression profiles in liver regeneration with oval cell induction. Biochem Biophys Res Commun 2004, 317(2):370-376.
25. Butterworth R.F. Hepatic encephalopathy: a central neuroinflammatory disorder?. Hepatology 2011, 53(4):1372-1376.
26. Braitch M., Constantinescu C.S. The role of osteopontin in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS). Inflamm Allergy Drug Targets 2010, 9(4):249-256.
27. Comi C., Carecchio M., Chiocchetti A., et al. Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline. J Alzheimers Dis 2010, 19(4):1143-1148.
28. Helluin o, Chan C., Vilaire G., Mousa S., DeGrado W.F., Bennett J.S. The activation state of alpha v beta 3 regulates platelet and lymphocyte adhesion to intact and thrombin-cleaved osteopontin. J Biol Chem 2000, 275(24):18337-18343.
29. Litvinov R.I., Vilaire G., Shuman H., Benett J.S., Weisel J.W. Quantitative analysis of platelet alpha v beta 3 binding to osteopontin using laser tweezers. J Biol Chem 2003, 278(51):51285-51290.
30. Schiodt F.V., Balko J., Schilsky M., et al. Thrombopoietin in acute liver failure. Hepatology 2003, 37(3):558-561.
31. Stravitz R.T., Lisman T., Luketic V.A., et al. Minimal effects of acute liver injury/acute liver failure on hemeostasis as assessed by thromboelastography. J Hepatol 2012, 56:129-136.